Vistagen Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.60

+0.03 (+5.16%)

Analyst Consensus

Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 7 70%

Sell 3 30%

Price Target

Analyst Price Target +8,131.3% upside

Low Target $36.23

Average Target $49.47

High Target $53.77

Current Price $0.60

Current
$0.60

Target
$49.47

$36.23 $49.47 avg $53.77

Scenario Analysis

Bear Case

$36.23

5,928.3%

Low target

Base Case

$49.47

+8,131.3%

Avg target

Bull Case

$53.77

+8,846.8%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$5.14

-88.3% from high

52-Week Low

$0.43

+39.8% from low

Target vs 52W High

$49.47

+862.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%